New Search

If you are not happy with the results below please do another search

2034 search results for:

241

Navigo, Mannin agree to develop affinity ligand against a novel drug for treatment of COVID-19

Navigo Proteins, a premier protein engineering company and developer of affinity ligands for custom chromatography solutions and Mannin, a subsidiary of Mannin Research Inc. (MRI), have agreed to develop a Precision X affinity ligand against the fusion protein of Angiopoietin-1 and Complement 4 Binding Protein (ANG1-C4BP) for use in GMP manu­facturing. Mannin, and its parent […]

242

Ziath issues guide for common 2D barcode scanning problems and how to prevent them

2D barcoded tubes are a de facto standard for high integrity sample management. However, while 2D barcoded tubes offer excellent performance, to get the most from them requires a good knowledge of common 2D barcode scanning problems and how to prevent them. A 20-page guide from Ziath provides informative solutions to the most encountered scanning […]

243

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

INDIANAPOLIS – (October 31, 2022) – More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System. The company continues building a robust demonstrated application library as it announces an application development agreement with […]

244

New CRISPR-Cas approach permits more precise DNA cleavage

A team led by researchers at Massachusetts General Hospital (MGH) has overcome a major constraint for cutting and editing DNA by CRISPR-Cas enzymes and other technologies. The recent innovation, which is published in Nature Biotechnology [1], will simplify and expedite molecular cloning approaches and expand their utility.

247

Sebia acquires Zeus Scientific

Sebia, a global specialty diagnostic company providing solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, has acquired Zeus Scientific, an in vitro diagnostic (IVD) company based in New Jersey, U.S., specialized in autoimmune and infectious diseases techno- logies. Financial terms of the agreement are undisclosed.

248

ProtonDx awarded £365,000 Defra and Innovate UK grant to develop porcine lung disease diagnostic

ProtonDx, an Imperial College health technology spin-out company delivering cost-effective, ultra-rapid, accurate and portable molecular testing, has been awarded a £365,000 grant from Defra’s Farming Innovation Programme and UKRI’s Transforming Food Production Challenge (Innovate UK) to develop rapid, accurate, point-of-care tests for porcine lung diseases, in collaboration with Imperial College London.

249

Kupando raises €13 million in Series A funding round

Kupando, a Berlin-based biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious diseases, has closed its Series A funding round which raised €13 million.